These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 7180558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 3. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Kissling W, Möller HJ, Walter K, Wittmann B, Krueger R, Trenk D.
    Pharmacopsychiatry; 1985 May; 18(3):240-5. PubMed ID: 4011672
    [Abstract] [Full Text] [Related]

  • 5. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC, Kennedy NM, Gribbon D.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [Abstract] [Full Text] [Related]

  • 6. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S, Cookson JC, Silverstone T.
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [Abstract] [Full Text] [Related]

  • 7. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Nov; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 8. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 9. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
    Altamura AC, Mauri MC, Girardi T, Panetta B.
    Int J Clin Pharmacol Res; 1990 Jul; 10(4):223-8. PubMed ID: 2079381
    [Abstract] [Full Text] [Related]

  • 10. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC, Sweet RA, Chengappa KN, Reddy RR, Jeste DV.
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [Abstract] [Full Text] [Related]

  • 11. Side effects during long-term treatment with depot antipsychotic medication.
    Cookson JC.
    Clin Neuropharmacol; 1991 Nov; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
    [Abstract] [Full Text] [Related]

  • 12. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L, Jaffe A, Levine J.
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [Abstract] [Full Text] [Related]

  • 13. 12-month study of haloperidol decanoate in chronic schizophrenic patients.
    Gelders YG, Reyntijens AJ, Ash CW, Aerts TJ.
    Int Pharmacopsychiatry; 1982 Jun; 17(4):247-54. PubMed ID: 7185769
    [Abstract] [Full Text] [Related]

  • 14. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
    McKane JP, Robinson AD, Wiles DH, McCreadie RG, Stirling GS.
    Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
    [Abstract] [Full Text] [Related]

  • 15. [Chronic treatment of schizophrenia with injectable bromperidol decanoate].
    Suárez Richards M.
    Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):222-8. PubMed ID: 2870608
    [Abstract] [Full Text] [Related]

  • 16. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R, Kabesh Ia, Papezhova G.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep; 82(1):116-8. PubMed ID: 6121437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC, Jann MW, Lin HN, Piao-Chien C, Chang WH.
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J.
    Psychopharmacol Bull; 1984 Jul; 20(1):108-9. PubMed ID: 6371871
    [No Abstract] [Full Text] [Related]

  • 20. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
    Lemperiere T, Ropert R, Leger JM, Alexandre JY, Clerc G, Darondel A, Delaunay J, Delteil P, Malauzat D, Raynaud J.
    Encephale; 1984 Jul; 10(5):217-22. PubMed ID: 6519017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.